✦ LIBER ✦

Treatment of the agitation of late-life psychosis and Alzheimer’s disease

✍ Scribed by C Salzman

Book ID: 119566264
Publisher: Elsevier Science
Year: 2001
Tongue: French
Weight: 62 KB
Volume: 16
Category: Article
ISSN: 0924-9338
DOI: 10.1016/s0924-9338(00)00525-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Markov Model of the Cost Effectiveness

A Markov Model of the Cost Effectiveness of Olanzapine Treatment for Agitation and Psychosis in Alzheimer’s Disease

✍ Stephanie Kirbach, Kit Simpson, Paul J. Nietert, Jacobo Mintzer 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 129 KB

Pharmacological Treatment of the Psychos

Pharmacological Treatment of the Psychosis of Alzheimer’s Disease

✍ Madhusoodanan, Subramoniam; Shah, Payal; Brenner, Ronald; Gupta, Sanjay 📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 141 KB

Early Life Socioeconomic Status and Late

Early Life Socioeconomic Status and Late Life Risk of Alzheimer’s Disease

✍ Wilson, Robert S.; Scherr, Paul A.; Hoganson, George; Bienias, Julia L.; Evans, 📂 Article 📅 2005 🏛 S. Karger AG 🌐 English ⚖ 105 KB

PMH35 COST-EFFECTIVENESS OF MEMANTINE IN

PMH35 COST-EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATE AND SEVERE ALZHEIMER'S DISEASE PATIENTS WITH AGITATION, AGGRESSION AND PSYCHOSIS—THE UK EXAMPLE

✍ Rive, B; Grishchenko, M; Guilhaume, C; Katona, C; Lamure, M; Livingston, G; Toum 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

P2-277: Prazosin for treatment of disrup

P2-277: Prazosin for treatment of disruptive agitation in Alzheimer's disease

✍ Wang, Lucy Y.; Petrie, Eric C.; Rohde, Kirsten; Hart, Kim L.; Hoff, David J.; Sh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Mid-life smoking and late-life Alzheimer

Mid-life smoking and late-life Alzheimer's disease: The Honolulu-Asia aging study

✍ Suzanne L. Tyas; George W. Ross; Richard J. Havlik; Lon R. White; Lenore J. Laun 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 175 KB